About Apostrophe
Apostrophe is a company based in Oakland (United States) founded in 2012 by Ben Holber, Ryan Hambley, and Chris Minnich was acquired by Hims in June 2021. The company has 61 employees as of December 31, 2022. Apostrophe operates in a competitive market with competitors including Nurx, Icebreaker Health, Thirty Madison, PipelineRx and DiRx Health, among others.
- Headquarter Oakland, United States
- Employees 61 as on 31 Dec, 2022
- Founders Ben Holber, Ryan Hambley, Chris Minnich
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apostrophe
Investors in Apostrophe
Apostrophe has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Hims, FJ Labs and 500 Global.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on marketplaces, gaming, web3, fintech, and multiple sectors
|
Locked | Locked | Locked | |
|
Venture capital and acceleration are provided to tech startups.
|
Locked | Locked | Locked | |
|
Online platform offering telehealth services for men's wellness
|
Locked | Locked | Locked |
Investor details for Apostrophe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apostrophe
Investment portfolio details for Apostrophe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apostrophe
Detailed financials for Apostrophe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apostrophe Comparisons
Peer comparison for Apostrophe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apostrophe
Apostrophe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nurx, Icebreaker Health, Thirty Madison, PipelineRx and DiRx Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Online prescriptions and delivery of contraceptives and PrEP are facilitated.
|
|
| Locked | Locked | Locked |
Provider of remote patient consultation services and online delivery of medical care products
|
|
| Locked | Locked | Locked |
Virtual care and personalized treatments for chronic conditions are provided.
|
|
| Locked | Locked | Locked |
24/7 telepharmacy and software solution provider
|
|
| Locked | Locked | Locked |
E-prescription solutions for pharmacy medication management are provided.
|
Detailed competitors of Apostrophe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apostrophe
Complete news archive for Apostrophe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apostrophe
Apostrophe was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Apostrophe is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Ben Holber is the current CEO of Apostrophe. They have also founded this company.
As of Dec 31, 2022, the latest employee count at Apostrophe is 61.
Apostrophe was founded in 2012 in Oakland, United States, and operates within the health technology sector focused on dermatology. An online platform is provided where users upload images of skin conditions for review by licensed professionals. Diagnoses are conducted remotely, leading to the creation of personalized treatment plans. Prescriptions are fulfilled and shipped directly to users addresses as needed.
Apostrophe's top competitors include Icebreaker Health, Nurx and Thirty Madison.
Apostrophe has 3 investors. Key investors include Hims, FJ Labs, and 500 Global.